OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmaceutical Sciences is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Design and development of microformulations for rapid release of small molecules and oligonucleotides	303
Some things old, new and borrowed: Delivery of dabrafenib and vemurafenib to melanoma cells via self-assembled nanomicelles based on an amphiphilic dendrimer	206
Novel thermosensitive small multilamellar lipid nanoparticles with promising release characteristics made by dual centrifugation	108
From extractables to exposure data: Sensitivity analysis of extrapolation algorithms with focus on USP 〈665〉	97
A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatment	93
Impact of vial quality on interactions, particle formation, container closure integrity, and gas permeability for frozen drug product storage	90
Sodium-glucose co-transporter-2 inhibitors and epicardial adiposity	85
Deoxycholic acid-functionalised nanoparticles for oral delivery of rhein	84
Evaluation of the increase of the thymoquinone permeability formulated in polymeric micelles: In vitro test and in vivo toxicity assessment in Zebrafish embryos	76
On the usefulness of four in vitro methods in assessing the intraluminal performance of poorly soluble, ionisable compounds in the fasted state	70
Development of gliclazide ionic liquid and the transdermal patches: An effective and noninvasive sustained release formulation to achieve hypoglycemic effects	69
Using molecularly dissolved drug concentrations in PBBMs improves the prediction of oral absorption from supersaturating formulations	61
Population pharmacokinetic analysis in children with different diseases treated with mycophenolate mofetil—Integrated analysis of clinical trials and real-world clinical data	61
Preparation, physicochemical characterization, ex vivo, and in vivo evaluations of asiatic acid-loaded solid lipid nanoparticles formulated with natural waxes for nose-to-brain delivery	61
Retraction notice to “Transdermal delivery of flurbiprofen from polyoxypropylene-polyoxyethylene block copolymer stabilized reduced graphene oxide to manage pain in spondylitis: In vitro and in vivo s	56
Effect of different doses of colchicine on high sensitivity C-reactive protein in patients with acute minor stroke or transient ischemic attack: A pilot randomized controlled trial	56
Functionalized FcRn-targeted nanosystems for oral drug delivery: A new approach to colorectal cancer treatment	52
Effect of process parameters in high shear granulation on characteristics of a novel co-processed mesoporous silica material	50
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators	49
Engineered mucoadhesive microparticles of formoterol/budesonide for pulmonary administration	49
Miniaturized screening and performance prediction of tailored subcutaneous extended-release formulations for preclinical in vivo studies	49
Do we really target the receptors? Deposition and co-deposition of ICS-LABA fixed combination drugs	49
Advances in formulation and manufacturing strategies for the delivery of therapeutic proteins and peptides in orally disintegrating dosage forms	48
Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes – detailed studies on CYP3A inhibitors	48
Polymorphs of a 1:1 salt of sulfadiazine and piperazine–relative stability, dissolution studies, pharmacokinetics and anti-meningitis efficiency	47

Enhancement of skin permeation of fluorescein isothiocyanate-dextran 4 kDa (FD4) and insulin by thermalporation	46
Relationship between the risk of idiosyncratic drug toxicity and formation and degradation profiles of acyl-glucuronide metabolites of nonsteroidal anti-inflammatory drugs in rat liver microsomes	46
In vitro dissolution/permeation tools for amorphous solid dispersions bioavailability forecasting I: Experimental design for PermeaLoop™	46
3D printed extended-release hydrochlorothiazide tablets	45
Influence of P-glycoprotein on pulmonary disposition of the model substrate [11C]metoclopramide assessed by PET imaging in rats	44
Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis	44
Pharmaceutical 3D-printing of nanoemulsified eucalypt extracts and their antimicrobial activity	44
A prestin-targeting peptide-guided drug delivery system rearranging concentration gradient in the inner ear: An improved strategy against hearing loss	43
Enhanced solubility and biopharmaceutical performance of atorvastatin and metformin via electrospun polyvinylpyrrolidone-hyaluronic acid composite nanoparticles	43
Does the circulating ketoconazole metabolite N-deacetyl ketoconazole contribute to the drug-drug interaction potential of the parent compound?	41
Increasing the efficacy of abiraterone - from pharmacokinetics, through therapeutic drug monitoring to overcoming food effects with innovative pharmaceutical products	40
Stability of high concentrated triple intrathecal therapy for pediatrics and mitigation strategies	39
Evaluating the influence of the initial high molecular weight level on monoclonal antibody particle formation kinetics using a short-term chemical stress study	38
Editorial Board	38